The term «parapsoriasis» includes skin conditions of different genesis manifested by rashes that resemble psoriatic papules or plaques but are not associated with psoriasis. There are two main forms of parapsoriasis: plaque and lichenoid. Lichenoid parapsoriasis is subdivided into chronic and acute parapsoriasis (Mucha—Habermann disease, varioliform parapsoriasis, or parapsoriasis lichenoides et varioliformis acuta). The clinical presentation of acute varioliform parapsoriasis includes 2–8 mm papules with necrosis in the center, small pustules, scars, and pigmentation on the skin. When localized on the skin of the face and other exposed areas of the body, these rashes are a significant cosmetic defect. We describe a clinical case of varioliform parapsoriasis in a 1-year 3-month boy who was admitted to the pediatric department of the Republican Center of Skin and Venereological Diseases of the Republic of Dagestan. The patient did not have a verified diagnosis within 3 months of referral to primary care specialists and therefore did not receive appropriate therapy. The treatment was carried out for toxicoderma, atopic dermatitis, and contact allergic dermatitis, with no effect. The patient developed atrophic scars during this period, including on the facial skin. In the hospital, the patient was treated with desensitizing agents, antibiotics, topical methylene blue solution, Levomekol ointment, and topical corticosteroids. The treatment outcome was recovery. The cosmetic defect due to atrophic scars could be prevented with the timely identification of parapsoriasis and its adequate therapy. In such cases, as early as the first week of therapy with no effect, the clinical diagnosis must be verified, and treatment change should be submitted to the medical board with the involvement of third-level experts and telemedicine technology, if necessary.